Medical News: Heart Risk Prompts FDA to Pull IBS Agent Tegaserod ...
ROCKVILLE, Md. -- The FDA said today that Novartis has halted sales of tegaserod (Zelnorm), its agent for irritable bowel syndrome and constipation, following ...
Irritable Bowel Syndrome News
Dependable irritable bowel syndrome (IBS) support, education ... Novartis' irritable bowel syndrome (IBS) treatment ZelmacŪ approved in Switzerland (Novartis) ...
Irritable bowel syndrome - Wikipedia, the free encyclopedia
Irritable bowel syndrome synonymous with GILL/HT/IB. Classification and external ... Novartis agreed to voluntarily suspend marketing of the drug in the United ...
Novartis Pharmaceuticals Corporation
Links to Pharmacology Research Partners. ... Novartis Makes Accessing Prescription Assistance and Disease Management Programs ...
Zelnorm - Safer Alternatives to Zelnorm for Irritable Bowel Syndrome ...
Zelnorm - Safer Alternatives to Zelnorm Medication for Constipation & Bloating from Irritable Bowel Syndrome (IBS) ... FDA has ordered Novartis to study how ...
Novartis Animal Health Canada Inc.
Offers products, customer support, and a veterinary library.
Irritable bowel syndrome - Wikipedia, the free encyclopedia
Irritable bowel syndrome synonymous with GILL/HT/IB. Classification and external ... Novartis agreed to voluntarily suspend marketing of the drug in the United ...
Zelnorm (Tegaserod Maleate)
Medication for women that treats the irritable bowel syndrome symptoms of constipation, abdominal pain or discomfort, and bloating. From Novartis.
Novartis Committed To Making Zelnorm(R) Available For Women With ...
... of Zelnorm(R) (tegaserod) for the treatment of women with irritable bowel s ... Irritable Bowel Syndrome with Constipation (IBS-C) and Zelnorm ...
